Differential sympathetic activation induced by intermittent hypoxia and sleep loss in rats: Action of angiotensin (1-7)

Autonomic Neuroscience: Basic and Clinical

Volumn 160, Issue 1-2, 2011, Pages 32-36

  Perry, Juliana C ^a   Bergamaschi, Cássia T ^a   Campos, Ruy R ^a   Andersen, Monica L ^a   Casarini, Dulce E ^a   Tufik, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin 1 7; Hypoxia; Renin angiotensin system; Sleep restriction; Sympathetic activity

Indexed keywords

ANGIOTENSIN[1-7];

ADRENERGIC SYSTEM; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMODYNAMIC PARAMETERS; HYPOXIA; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP DEPRIVATION; RENAL SYMPATHETIC NERVE ACTIVITY; RENAL SYMPATHETIC NERVOUS SYSTEM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP DISORDER; SYMPATHETIC TONE;

ANGIOTENSIN I; ANIMALS; ANOXIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; HEMODYNAMICS; HYPERTENSION; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM; SLEEP APNEA SYNDROMES; SLEEP DEPRIVATION; SYMPATHETIC NERVOUS SYSTEM;

EID: 79551552383     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.11.006     Document Type: Article

References (33)

1. Bao G., Metreveli N., Li R., Taylor A., Fletcher E.C. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J. Appl. Physiol. 1997, 83:95-101.
2. Braga V.A., Soriano R.N., Machado B.H. Sympathoexcitatory response to peripheral chemoreflex activation is enhanced in juvenile rats exposed to chronic intermittent hypoxia. Exp. Physiol. 2006, 91:1025-1031.
3. Casarini D.E., Boim M.A., Stella R.C., Krieger-Azzolini M.H., Krieger J.E., Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am. J. Physiol. 1997, 272:405-409.
4. Dematteis M., Julien C., Guillermet C., Sturm N., Lantuejoul S., Mallaret M., et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am. J. Respir. Crit. Care Med. 2008, 177:227-235.
5. Ferrario C.M., Trask A.J., Jessup J.A. Advances in the biochemical and functional roles of angiotensin converting enzyme 2 and angiotensin-(1-7) in the regulation of cardiovascular function. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:2281-2290.
6. Ferrario C.M. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006, 47:515-521.
7. Fletcher E.C. Physiological consequences of intermittent hypoxia: systemic blood pressure. J. Appl. Physiol. 2001, 90:1600-1605.
8. Fletcher E.C., Orolinova N., Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J. Appl. Physiol. 2002, 92:627-633.
9. Friedland J., Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am. J. Clin. Pathol. 1976, 66:416-424.
10. Guild S.J., Barrett C.J., McBryde F.D., Van Vliet B.N., Head G.A., Burke S.L., et al. Quantifying sympathetic nerve activity; problems and pitfalls, the need for standardization. Exp. Physiol. 2009, 95:41-50.
11. Hochachka P.W. Mechanism and evolution of hypoxia-tolerance in humans. J. Exp. Biol. 1998, 201:1243-1254.
12. Hui A.S., Striet J.B., Gudelsky G., Soukhova G.K., Gozal E., Beitner-Johnson D., et al. Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension 2003, 42:1130-1136.
13. Inagami T. The renin-angiotensin system. Essays Biochem. 1994, 28:147-164.
14. Lavie L., Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med. Hypotheses 2006, 66:1069-1073.
15. Lavie P., Herer P., Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br. Med. J. 2000, 320:479-482.
16. Li J., Savransky V., Nanayakkara A., Smith P.L., O'Donnell C.P., Polotsky V.Y. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J. Appl. Physiol. 2007, 102:557-563.
17. Machado R.B., Suchecki D., Tufik S. Sleep homeostasis in rats assessed by a long-term intermittent paradoxical sleep deprivation protocol. Behav. Brain Res. 2005, 160:356-364.
18. Ostadal B., Ostadalova I., Dhalla N.S. Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol. Rev. 1999, 79:635-659.
19. Perry J.C., D'Almeida V., Souza F.G., Schoorlemmer G.H., Colombari E., Tufik S. Effects of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats. Respir. Physiol. Neurobiol. 2007, 156:250-258.
20. Perry J.C., D'Almeida V., Lima M.M.S., Godoi F., Vital M.A.B.F., Oliveira M.G.M., et al. Chronic intermittent hypoxia and sleep restriction associations: motor, cognition and neurochemical alterations. Behav. Brain Res. 2008, 189:373-380.
21. Prabhakar N.R., Fields R.D., Baker T., Fletcher E.C. Intermittent hypoxia: cell to system. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:524-528.
22. Prabhakar N.R., Peng Y.J., Jacono F.J., Kumar G.K., Dick T.E. Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin. Exp. Pharmacol. Physiol. 2005, 32:447-449.
23. Prabhakar N.R., Dick T.E., Nanduri J., Kumar G.K. Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp. Physiol. 2007, 92:39-44.
24. Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 2004, 383:45-51.
25. Ronchi F.A., Irigoyen M.C., Casarini D.E. Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus. J. Renin Angiotensin Aldosterone Syst. 2007, 8:34-41.
26. Santos R.A., Ferreira A.J. Angiotensin-(1-7) and the renin-angiotensin system. Curr. Opin. Nephrol. Hypertens. 2007, 16:122-128.
27. Silva L.C., Fontes M.A., Campagnole-Santos M.J., Khosla M.C., Campos R.R., Guertzenstein P.G., et al. Cardiovascular effects produced by micro-injection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla. Brain Res. 1993, 613:321-325.
28. Schindler C., Bramlage P., Kirch W., Ferrario C.M. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc. Health Risk Manag. 2007, 3:125-137.
29. Van der Wouden E.A., Ochodnicky P., van Dokkum R.P., Roks A.J., Deelman L.E., de Zeeuw D., et al. The role of angiotensin (1-7) in renal vasculature of the rat. J. Hypertens. 2006, 24:1971-1978.
30. Weiss J.W., Liu M.D., Huang J. Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp. Physiol. 2007, 92:21-26.
31. Yang Z., Coote J.H. The role of supraspinal vasopressin and glutamate neurons in an increase in renal sympathetic activity in response to mild haemorrhage in the rat. Exp. Physiol. 2006, 91:791-797.
32. Zisman L.S., Keller R.S., Weaver B., Lin Q., Speth R., Bristow M.R., et al. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 2003, 108:1707-1712.
33. Zoccal D.B., Bonagamba L.G., Oliveira F.R., Antunes-Rodrigues J., Machado B.H. Increased sympathetic activity in rats submitted to chronic intermittent hypoxia. Exp. Physiol. 2007, 92:79-85.